Delta-Fly Pharma, Inc.'s total assets for Q3 2025 were ¥823.00M, an increase of 93.65% from the previous quarter. JP:4598 total liabilities were ¥133.00M for the fiscal quarter, a 19.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.